Showing 1 - 3 results of 3 for search 'Vip Viprakasit', query time: 0.01s Refine Results
  1. 1
    JUSTIFICATION OF UNIVERSAL IRON SUPPLEMENTATION FOR INFANTS 6-12 MONTHS IN REGIONS WITH A HIGH PREVALENCE OF THALASSEMIA

    JUSTIFICATION OF UNIVERSAL IRON SUPPLEMENTATION FOR INFANTS 6-12 MONTHS IN REGIONS WITH A HIGH PREVALENCE OF THALASSEMIA by Phakatip Sinlapamongkolkul, Pacharapan Surapolchai, Vip Viprakasit

    Published 2023-08-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    LONG-TERM EFFECTIVENESS, SAFETY, AND TOLERABILITY OF TWICE-DAILY DOSING WITH DEFERASIROX IN CHILDREN WITH TRANSFUSION-DEPENDENT THALASSEMIAS UNRESPONSIVE TO STANDARD ONCE-DAILY DOSING

    LONG-TERM EFFECTIVENESS, SAFETY, AND TOLERABILITY OF TWICE-DAILY DOSING WITH DEFERASIROX IN CHILDREN WITH TRANSFUSION-DEPENDENT THALASSEMIAS UNRESPONSIVE TO STANDARD ONCE-DAILY DOS... by Jassada Buaboonnam, Chayamon Takpradit, Vip Viprakasit, Nattee Narkbunnam, Nassawee Vathana, Kamon Phuakpet, Kleebsabai Sanpakit, Bunchoo Pongtanakul

    Published 2021-10-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Luspatercept versus mitapivat for non‐transfusion‐dependent β‐thalassemia: Dare to compare?

    Luspatercept versus mitapivat for non‐transfusion‐dependent β‐thalassemia: Dare to compare? by Khaled M. Musallam, Sujit Sheth, Maria Domenica Cappellini, Kevin H. M. Kuo, Antonis Kattamis, Yesim Aydinok, Vip Viprakasit, Ali T. Taher

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: